Los Angeles, California Dec 19, 2022 (Issuewire.com) - ViBo Health, a consumer-oriented medical device company, is excited to announce that we have been selected as one of the six winning startups of the inaugural 2022 Care In Space Challenge. We are also pleased to announce that we have received an equity investment from Boryung Corp, a major Korean pharmaceutical development company, as part of its win.
As a winner, ViBo Health gains admission into the Care in Space 13-week accelerator program operated by Starburst Aerospace to help bring their ideas to fruition. We also gain access to Axiom Space’s integration team which has successfully flown dozens of payloads to the International Space Station.
These opportunities by Boryung Corp., Axiom Space, and Starburst Aerospace allow ViBo Health to be a part of the initiative that is working toward enabling the future of humanity in space and on earth.
About ViBo Health
Based in Coimbra (Portugal) and Los Angeles (USA), ViBo Health is working to make predictive, personalized and precision healthcare a reality. We are creating a world where everyone can track their health status using a quick and painless wrist scan. ViBo Health Scanners are designed to acquire causal health insights through metabolomics, including vitamins, cholesterols, and diabetes parameters, giving deep insights and trends into health, wellness, and fitness. ViBo Health is making smart health tracking available to space travelers and empowered consumers. In space health, we see monitoring and sustaining crew health before, during, and after space habitation as crucial to developing the space economy. On earth, we see our mission as letting everyone answer the question, “How am I doing?” for their health.
Media Contact
ViBo Health press@vibo.health http://www.vibo.health
